Cost considerations in sedation, analgesia, and neuromuscular blockade in the intensive care unit

Citation
Jp. Kress et Jb. Hall, Cost considerations in sedation, analgesia, and neuromuscular blockade in the intensive care unit, SEM RESP CR, 22(2), 2001, pp. 199-209
Citations number
68
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
ISSN journal
10693424 → ACNP
Volume
22
Issue
2
Year of publication
2001
Pages
199 - 209
Database
ISI
SICI code
1069-3424(2001)22:2<199:CCISAA>2.0.ZU;2-P
Abstract
Sedation of critically ill patients is a costly endeavor. Costs of commonly used intensive care unit (ICU) sedatives range from pennies to more than $ 500 per day. Although the agents account for some of this expense, complica tions related to the use of these drugs in the ICU produce even greater cos ts. Prolongation of mechanical ventilation and length of stay are some of t he common complications resulting from non-ideal use of these drugs. Sedati ve agents also impair neurological evaluation in many critically ill patien ts, which may mask detection of acute delirium resulting from intercurrent illness or intracranial catastrophes and can lead to excessive diagnostic t esting. Opiates may result in gastrointestinal dysfunction with resulting m alnutrition and perhaps bacterial translocation and sepsis, Neuromuscular b locking agents may cause prolonged paralysis and disability in critically i ll patients who receive them. Simple dosing strategies based on pharmacolog ical principles may decrease the incidence of these costly problems.